BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 23449072)

  • 1. Interaction between misfolded PrP and the ubiquitin-proteasome system in prion-mediated neurodegeneration.
    Lin Z; Zhao D; Yang L
    Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):477-84. PubMed ID: 23449072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Misfolded PrP and a novel mechanism of proteasome inhibition.
    Andre R; Tabrizi SJ
    Prion; 2012; 6(1):32-6. PubMed ID: 22453175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prions and the proteasome.
    Deriziotis P; Tabrizi SJ
    Biochim Biophys Acta; 2008 Dec; 1782(12):713-22. PubMed ID: 18644436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay between 20S proteasomes and prion proteins in scrapie disease.
    Amici M; Cecarini V; Cuccioloni M; Angeletti M; Barocci S; Rossi G; Fioretti E; Keller JN; Eleuteri AM
    J Neurosci Res; 2010 Jan; 88(1):191-201. PubMed ID: 19658198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous prion protein conversion is required for prion-induced neuritic alterations and neuronal death.
    Cronier S; Carimalo J; Schaeffer B; Jaumain E; Béringue V; Miquel MC; Laude H; Peyrin JM
    FASEB J; 2012 Sep; 26(9):3854-61. PubMed ID: 22661006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prion protein is ubiquitinated after developing protease resistance in the brains of scrapie-infected mice.
    Kang SC; Brown DR; Whiteman M; Li R; Pan T; Perry G; Wisniewski T; Sy MS; Wong BS
    J Pathol; 2004 May; 203(1):603-8. PubMed ID: 15095484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Misfolded PrP impairs the UPS by interaction with the 20S proteasome and inhibition of substrate entry.
    Deriziotis P; André R; Smith DM; Goold R; Kinghorn KJ; Kristiansen M; Nathan JA; Rosenzweig R; Krutauz D; Glickman MH; Collinge J; Goldberg AL; Tabrizi SJ
    EMBO J; 2011 Jul; 30(15):3065-77. PubMed ID: 21743439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental approaches to the interaction of the prion protein with nucleic acids and glycosaminoglycans: Modulators of the pathogenic conversion.
    Silva JL; Vieira TC; Gomes MP; Rangel LP; Scapin SM; Cordeiro Y
    Methods; 2011 Mar; 53(3):306-17. PubMed ID: 21145399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prion-mediated neurodegeneration is associated with early impairment of the ubiquitin-proteasome system.
    McKinnon C; Goold R; Andre R; Devoy A; Ortega Z; Moonga J; Linehan JM; Brandner S; Lucas JJ; Collinge J; Tabrizi SJ
    Acta Neuropathol; 2016 Mar; 131(3):411-25. PubMed ID: 26646779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of proteasomes in prion disease.
    Zhu T; Hayat Khan S; Zhao D; Yang L
    Acta Biochim Biophys Sin (Shanghai); 2014 Jul; 46(7):531-9. PubMed ID: 24829398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prion-Associated Neurodegeneration Causes Both Endoplasmic Reticulum Stress and Proteasome Impairment in a Murine Model of Spontaneous Disease.
    Otero A; Betancor M; Eraña H; Fernández Borges N; Lucas JJ; Badiola JJ; Castilla J; Bolea R
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular prion protein mediates toxic signaling of amyloid beta.
    Resenberger UK; Winklhofer KF; Tatzelt J
    Neurodegener Dis; 2012; 10(1-4):298-300. PubMed ID: 22156337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular tolerance of prion protein PrP in yeast involves proteolysis and the unfolded protein response.
    Apodaca J; Kim I; Rao H
    Biochem Biophys Res Commun; 2006 Aug; 347(1):319-26. PubMed ID: 16808901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic prions and other human neurodegenerative proteinopathies.
    Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
    Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporin-A-induced prion protein aggresomes are dynamic quality-control cellular compartments.
    Ben-Gedalya T; Lyakhovetsky R; Yedidia Y; Bejerano-Sagie M; Kogan NM; Karpuj MV; Kaganovich D; Cohen E
    J Cell Sci; 2011 Jun; 124(Pt 11):1891-902. PubMed ID: 21558416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prion and anti-codon usage: does infectious PrP alter tRNA abundance to induce misfolding of PrP?
    Rechavi O; Kloog Y
    Med Hypotheses; 2009 Feb; 72(2):193-5. PubMed ID: 18809261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease-related prion protein forms aggresomes in neuronal cells leading to caspase activation and apoptosis.
    Kristiansen M; Messenger MJ; Klöhn PC; Brandner S; Wadsworth JD; Collinge J; Tabrizi SJ
    J Biol Chem; 2005 Nov; 280(46):38851-61. PubMed ID: 16157591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strain-specific effects of reducing agents on the cell-free conversion of recombinant prion protein into a protease-resistant form.
    Imamura M; Kato N; Okada H; Iwamaru Y; Shimizu Y; Mohri S; Yokoyama T
    Microbiol Immunol; 2011 Sep; 55(9):633-40. PubMed ID: 21645053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein.
    Piening N; Weber P; Giese A; Kretzschmar H
    Biochem Biophys Res Commun; 2005 Jan; 326(2):339-43. PubMed ID: 15582583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.